Table 2.
Risk Factor | Experimental Model | Amino Acids | Findings | Reference |
---|---|---|---|---|
Hypertension | 4288 participants aged 20–70 years without hypertension (3-year follow-up) | Dietary intakes of BCAAs (valine, leucine, and isoleucine) | Higher BCAA intake, particularly valine, is associated with a higher risk of incident hypertension. | [129] |
8589 Japanese subjects | Plasma AAs | Higher intake of aromatic AAs is associated with s significantly higher risk of developing hypertension. | [130] | |
4287 adults (41.9% men), aged 20–70 years. | Dietary intake of AAs | High dietary intake of Leu.Ser/Thr.Trp ratio is associated with a higher risk of incident hypertension. | [131] | |
172 South African adolescents (105 girls, ages 13 to <18 years) | Circulating HCY concentrations | Of these adolescents, 40% had elevated BP, of whom 37% fell in the lowest and 38% in the highest HCY tertiles. | [132] | |
Normotensive or spontaneously hypertensive rats | L-Tyrosine, Tryptophan, Leucine, Isoleucine, Valine, Alanine, Arginine, and Aspartate | In spontaneously hypertensive rats, tyrosine (50 mg/kg) reduced BP by about 12 mmHg, while 200 mg/kg reduced BP by about 40 mmHg. Tryptophan injection (225 mg/kg) reduced BP in spontaneously hypertensive rats, but only by about half as much as an equivalent dose of tyrosine. Other AAs have no effect on BP. | [133] | |
Spontaneously hypertensive rat | L-tyrosine | Intraventricular injection of 15 micrograms of l-tyrosine results in a significantly lower BP in the spontaneously hypertensive rat. | [134] | |
4680 persons aged 40–59 years from China, Japan, the United Kingdom, and the United States | Dietary AA (glutamic, proline, phenylalanine, serine, and cystine) | Dietary glutamic acid (percentage of total protein intake) was inversely related to BP. | [135] |
Legend: BCAA: Branched-chain amino acid; AA: Amino acids; Leu: Leucine; Ser: Serine; Thr: Threonine; Trp: Tryptophan; BP: Blood pressure.